S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
1907, 1929, 1998, 2007--and now 2023? (Ad)
Things to know about California's new proposed rules for insurance companies
MarketBeat Week in Review – 9/18 - 9/22
MarketBeat's Top 5 Stock Picks - Just Released (Ad)
How major US stock indexes fared Friday, 9/22/2023
The federal government is headed into a shutdown. What does it mean, who's hit and what's next?
MarketBeat's Top 5 Stock Picks - Just Released (Ad)
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
New York to require flood disclosures in home sales as sea levels rise and storms worsen
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
1907, 1929, 1998, 2007--and now 2023? (Ad)
Things to know about California's new proposed rules for insurance companies
MarketBeat Week in Review – 9/18 - 9/22
MarketBeat's Top 5 Stock Picks - Just Released (Ad)
How major US stock indexes fared Friday, 9/22/2023
The federal government is headed into a shutdown. What does it mean, who's hit and what's next?
MarketBeat's Top 5 Stock Picks - Just Released (Ad)
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
New York to require flood disclosures in home sales as sea levels rise and storms worsen
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
1907, 1929, 1998, 2007--and now 2023? (Ad)
Things to know about California's new proposed rules for insurance companies
MarketBeat Week in Review – 9/18 - 9/22
MarketBeat's Top 5 Stock Picks - Just Released (Ad)
How major US stock indexes fared Friday, 9/22/2023
The federal government is headed into a shutdown. What does it mean, who's hit and what's next?
MarketBeat's Top 5 Stock Picks - Just Released (Ad)
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
New York to require flood disclosures in home sales as sea levels rise and storms worsen
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
1907, 1929, 1998, 2007--and now 2023? (Ad)
Things to know about California's new proposed rules for insurance companies
MarketBeat Week in Review – 9/18 - 9/22
MarketBeat's Top 5 Stock Picks - Just Released (Ad)
How major US stock indexes fared Friday, 9/22/2023
The federal government is headed into a shutdown. What does it mean, who's hit and what's next?
MarketBeat's Top 5 Stock Picks - Just Released (Ad)
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
New York to require flood disclosures in home sales as sea levels rise and storms worsen
NASDAQ:KTRA

Kintara Therapeutics (KTRA) News Today

$4.36
0.00 (0.00%)
(As of 09/22/2023 ET)
Compare
Today's Range
$4.17
$4.48
50-Day Range
$3.30
$4.92
52-Week Range
$2.70
$15.50
Volume
13,227 shs
Average Volume
15,714 shs
Market Capitalization
$7.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SourceHeadline
seekingalpha.com logoKintara Therapeutics Non-GAAP EPS of -$9.27
seekingalpha.com - September 19 at 10:27 PM
finance.yahoo.com logoKintara Therapeutics Announces Fiscal 2023 Year Financial Results and Provides Corporate Update
finance.yahoo.com - September 18 at 7:30 PM
uk.finance.yahoo.com logoKTRA - Kintara Therapeutics, Inc.
uk.finance.yahoo.com - September 14 at 8:06 PM
MarketBeat logoKintara Therapeutics (NASDAQ:KTRA) Shares Down 3.1%
americanbankingnews.com - September 14 at 1:49 AM
finance.yahoo.com logoKintara Therapeutics to Present at the 2023 European Association for Neuro-Oncology Annual Meeting
finance.yahoo.com - September 5 at 10:32 AM
finance.yahoo.com logoKintara Therapeutics to Host Virtual KOL Event on VAL-083, A Potential First-in-Class Small Molecule Chemotherapeutic for Glioblastoma, on August 21, 2023
finance.yahoo.com - August 17 at 9:26 PM
finance.yahoo.com logoKintara Therapeutics to Present at the Emerging Growth Conference
finance.yahoo.com - August 9 at 8:24 AM
finance.yahoo.com logoPresenting on the Emerging Growth Conference on August 9 & 10 Register Now
finance.yahoo.com - August 8 at 7:19 AM
msn.com logoBenzinga's Top Ratings Upgrades, Downgrades For July 14, 2023
msn.com - July 14 at 12:49 PM
finance.yahoo.com logoKintara (KTRA) Rises 41% on $2M Grant for Breast Cancer Therapy
finance.yahoo.com - June 30 at 1:27 PM
benzinga.com logoKintara Therapeutics Stock Is Trading Higher: What's Driving The Action?
benzinga.com - June 29 at 10:02 AM
finance.yahoo.com logoKintara Therapeutics Awarded $2.0 Million National Institutes of Health SBIR Grant to Support the Clinical Development of REM-001
finance.yahoo.com - June 28 at 6:15 PM
finance.yahoo.com logoKintara Therapeutics to Participate in the Maxim Group Virtual Healthcare Conference
finance.yahoo.com - June 16 at 10:38 AM
finance.yahoo.com logoKintara Therapeutics to Commemorate National Brain Tumor Awareness Month with Ringing the Bell at Nasdaq Closing Along with Global Coalition for Adaptive Research and the National Brain Tumor Society
finance.yahoo.com - May 19 at 4:18 PM
msn.com logoRecap: Kintara Therapeutics Q3 Earnings
msn.com - May 12 at 5:52 AM
finance.yahoo.com logoKintara Therapeutics Announces Fiscal 2023 Third Quarter Financial Results and Provides Corporate Update
finance.yahoo.com - May 11 at 8:45 AM
finance.yahoo.com logoKintara Therapeutics to Present at the Sidoti Micro-Cap Virtual Conference
finance.yahoo.com - May 8 at 9:06 AM
finance.yahoo.com logoKintara Therapeutics to Present at the Aegis Capital Virtual Conference
finance.yahoo.com - May 1 at 10:47 AM
finance.yahoo.com logoKintara Therapeutics Announces Data Presentation at the 2023 American Association for Cancer Research Annual Meeting
finance.yahoo.com - April 14 at 1:15 PM
ca.finance.yahoo.com logoThese 4 Biotech Stocks Just Got ‘Fast Track’ Designation Greenlights
ca.finance.yahoo.com - March 17 at 2:38 PM
finance.yahoo.com logoKintara Therapeutics to Present Two Posters at the 2023 American Association for Cancer Research Annual Meeting
finance.yahoo.com - March 15 at 9:47 AM
finance.yahoo.com logoKintara Therapeutics Scheduled to Present at Two Conferences the Week of March 13, 2023
finance.yahoo.com - March 10 at 8:52 AM
finance.yahoo.com logoKintara Therapeutics Announces Fiscal 2023 Second Quarter Financial Results and Provides Corporate Update
finance.yahoo.com - February 14 at 5:11 PM
finance.yahoo.com logoKintara Therapeutics to Present at the 2023 BIO CEO & Investor Conference
finance.yahoo.com - January 30 at 9:06 AM
finance.yahoo.com logoKintara Therapeutics to Present at the Biotech Showcase Conference on January 10, 2023
finance.yahoo.com - January 9 at 9:32 AM
marketbeat.com logoIs Kintara Therapeutics A Hidden Gem?
marketbeat.com - December 30 at 1:00 AM
marketwatch.com logoKintara Therapeutics Shares Rise 29% After Orphan Drug Designation for VAL-083
marketwatch.com - December 15 at 3:02 PM
msn.com logoWhy Kintara Therapeutics Stock Is Seeing Blue Skies Thursday
msn.com - December 15 at 3:02 PM
finance.yahoo.com logoKintara Therapeutics Receives Orphan Drug Designation for VAL-083 for Treatment of Diffuse Intrinsic Pontine Glioma (DIPG)
finance.yahoo.com - December 15 at 10:02 AM
finance.yahoo.com logo10 Pump and Dump Stocks Hedge Funds Like
finance.yahoo.com - December 2 at 10:24 AM
baystreet.ca logoLatest Set of FDA Fast Track Designations Causing Optimism in Biotech Sector
baystreet.ca - December 1 at 12:38 PM
benzinga.com logoWave of FDA Fast Track Designations Sparks Renewed Interest in Biotech Sector That's Heating Up
benzinga.com - December 1 at 12:38 PM
finance.yahoo.com logoKintara Therapeutics to Participate at the RHK Capital Disruptive Growth Conference on December 5-6, 2022
finance.yahoo.com - December 1 at 12:38 PM
msn.com logoAnalyzing Kintara Therapeutics's Short Interest
msn.com - November 30 at 11:28 AM
finance.yahoo.com logoKintara Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
finance.yahoo.com - November 30 at 10:32 AM
marketbeat.com logo
marketbeat.com - November 30 at 9:34 AM
markets.businessinsider.com logoKintara: FDA Grants Fast Track Designation To REM-001 Therapy - Quick Facts
markets.businessinsider.com - November 28 at 4:52 PM
markets.businessinsider.com logoKintara Therapeutics Rallies As Its REM-001 To Treat Breast Cancer Gets Fast Track Designation
markets.businessinsider.com - November 28 at 4:52 PM
msn.com logoWhat's Going On With Kintara Therapeutics Stock?
msn.com - November 28 at 4:52 PM
seekingalpha.com logoKintara adds 26% on FDA Fast Track status for breast cancer candidate
seekingalpha.com - November 28 at 4:52 PM
marketwatch.com logoKintara Therapeutics Shares Rally Premarket on FDA Fast-Track Designation >KTRA
marketwatch.com - November 28 at 4:52 PM
finance.yahoo.com logoKintara Therapeutics Granted Fast Track Designation from FDA for REM-001 for Cutaneous Metastatic Breast Cancer
finance.yahoo.com - November 28 at 4:52 PM
finance.yahoo.com logoKintara Therapeutics Presents Three Posters at the 2022 Society for Neuro-Oncology Annual Meeting
finance.yahoo.com - November 18 at 12:59 PM
finance.yahoo.com logoKintara Announces One-for-Fifty Reverse Stock Split
finance.yahoo.com - November 11 at 9:55 AM
finance.yahoo.com logoKintara Therapeutics Announces Fiscal 2023 First Quarter Financial Results and Provides Corporate Update
finance.yahoo.com - November 9 at 6:59 PM
markets.businessinsider.com logoKintara Decides To Pause REM-001 Program - Quick Facts
markets.businessinsider.com - October 19 at 12:32 PM
finance.yahoo.com logoKintara Therapeutics Pauses REM-001 Program to Conserve Funds to Support VAL-083 International Registrational Study
finance.yahoo.com - October 19 at 12:32 PM
reuters.com logoKintara Therapeutics Inc
reuters.com - October 16 at 10:48 AM
finance.yahoo.com logoKintara Therapeutics Announces Fiscal 2022 Financial Results and Provides Corporate Update
finance.yahoo.com - September 27 at 9:12 AM
seekingalpha.com logoKTRA Kintara Therapeutics, Inc.
seekingalpha.com - September 20 at 8:21 PM
Get Kintara Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for KTRA and its competitors with MarketBeat's FREE daily newsletter.



KTRA Media Mentions By Week

KTRA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

KTRA
News Sentiment

-0.80

0.53

Average
Medical
News Sentiment

KTRA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

KTRA Articles
This Week

4

1

KTRA Articles
Average Week

Get Kintara Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for KTRA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:KTRA) was last updated on 9/23/2023 by MarketBeat.com Staff

My Account -